The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. — Stella
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(13 sites) Austria
Medical University Innsbruck, Innsbruck Germany
Bezirkskliniken Schwaben, Bezirkskrankenhaus Augsburg, Augsburg Universitätsklinik für Psychiatrie und Psychotherapie Bielefeld, Bielefeld LWL-Klinik Dortmund, Bereich Forschung & Wissenschaft, Dortmund University Hospital Frankfurt am Main - Goethe University, Frankfurt am Main Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Mainz Westfälische Wilhelms-Universität Münster, Münster Italy
Universita degli Studi di Brescia, Brescia University of Cagliari, Cagliari Università degli studi della Campania Luigi Vanvitelli, Naples Azienda Ospedaliero-Universitaria "Città della Salute e della Scienza di Torino", Turin Spain
Fundació Clínic per a la Recerca Biomèdica, Barcelona United Kingdom
King's College London, Psychiatry & Cognitive Neuroscience, London
Key details Collaborators
Universität Münster
Enrollment target
~418 participants
Primary completion
June 2028
Last updated September 2025